Meditor Group Ltd Q4 2022 significant ownership

Meditor Group Ltd is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Meditor Group Ltd Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
Shares Percentage
EXELIXIS, INC.15,001,0735.0%April 09, 2019EDGAR
VIVUS INC5,002,8965.0%December 19, 2012EDGAR
VIVUS INC6,177,5006.3%March 21, 2012EDGAR
VION PHARMACEUTICALS INC5,736,2007.6%February 15, 2008EDGAR
CYPRESS BIOSCIENCE INC1,864,6455.0%September 26, 2007EDGAR
ONYX PHARMACEUTICALS INC2,627,8004.8%September 12, 2007EDGAR
ACUSPHERE INC1,839,4214.0%July 26, 2007EDGAR
NOVACEA INC800,0003.4%June 11, 2007EDGAR
ATHEROGENICS INC1,361,8003.5%May 02, 2007EDGAR

Compare quarterly holdings

Export Meditor Group Ltd's holdings

EDGAR filings